Botto Riccardo, Riccio Valentina, Galosi Livio, Rossi Giacomo, Vincenzetti Silvia, Tambella Adolfo Maria, De Francesco Francesco, Pennasilico Luca, Riccio Michele, Salvaggio Alberto, Sassaroli Sara, Palumbo Piccionello Angela
School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione 93/95, 62024 Matelica, Italy.
Department of Reconstructive Surgery and Hand Surgery, University Hospital (AOU Ospedali Riuniti di Ancona), Via Conca 71, 60123 Ancona, Italy.
Animals (Basel). 2022 Jul 20;12(14):1844. doi: 10.3390/ani12141844.
The purpose of this study was to estimate the safety, feasibility, and efficacy of the intra-articular treatment of autologous microfragmented adipose tissue in dogs with spontaneous osteoarthritis (OA) in comparison with hyaluronic acid (HA), the standard intra-articular treatment. Specifically, it clinically evaluated pain and lameness, the radiographic progression of osteoarthritis, and synovial fluid inflammation. This was a prospective, single-center, parallel-group, randomized, controlled, in vivo clinical study. Participants ( = 40) received either a single intra-articular injection of microfragmented adipose tissue or a single intra-articular injection of HA (1:1). Clinical outcomes were determined using a specialistic clinician assessment obtained by the completion of a specific clinical form based on the Vesseur modified lameness classification system, a pain evaluation using the Visual Analogue Scale (VAS), the measurement of the range of motion (ROM) of the affected joint, limb circumference, and the owners' score evaluation using the Canine Brief Pain Inventory (CBPI) for up to 6 months after the time of injection. Patients underwent a radiographic examination to establish the degree of OA in the affected joint, and synovial fluid samples were collected to assess the biochemical environment of the joint and evaluate and quantify the cellular population and the presence of three specific inflammation biomarkers for up to 60 days. The results of this study suggest that microfragmented autologous adipose tissue is safe and can effectively relieve pain and improve function in dogs with spontaneous articular OA. This one-step procedure is simple, timesaving, cost-effective, minimally invasive, and eliminates the need for complex and time-intensive cell culture processing. Furthermore, the clinical evidence and cytological results suggest better long-term pain control, resulting in an improvement in joint function, compared to HA treatment. The canine spontaneous OA model could play a key role in developing successful treatments for human medicine.
本研究的目的是评估自体微片段脂肪组织关节内注射治疗自发性骨关节炎(OA)犬的安全性、可行性和有效性,并与关节内注射治疗的标准药物透明质酸(HA)进行比较。具体而言,本研究从临床角度评估了疼痛和跛行情况、骨关节炎的影像学进展以及滑液炎症。这是一项前瞻性、单中心、平行组、随机、对照的体内临床研究。40只受试犬被随机分为两组,每组各20只,分别接受单次关节内注射微片段脂肪组织或单次关节内注射HA。临床结果通过专业临床医生评估来确定,评估内容包括基于Vesseur改良跛行分类系统填写特定临床表格、使用视觉模拟量表(VAS)进行疼痛评估、测量患关节的活动范围(ROM)、肢体周长,以及在注射后长达6个月的时间内使用犬简短疼痛量表(CBPI)进行主人评分评估。受试犬接受了影像学检查以确定患关节的OA程度,并采集了滑液样本,以评估关节的生化环境,并在长达60天的时间内评估和量化细胞数量以及三种特定炎症生物标志物的存在情况。本研究结果表明,自体微片段脂肪组织是安全的,并且可以有效缓解自发性关节OA犬的疼痛并改善其功能。这一一步式操作简单、省时、经济高效、微创,并且无需进行复杂且耗时的细胞培养处理。此外,临床证据和细胞学结果表明,与HA治疗相比,微片段脂肪组织治疗能实现更好的长期疼痛控制,从而改善关节功能。犬自发性OA模型可能在开发成功的人类医学治疗方法中发挥关键作用。